Рубрика
Blog
-
2023
-
Roche’s Crovalimab Trial Reaches Endpoints in Patients With PNH
-
Aldeyra’s reproxalap for dry eye disease accepted by FDA
-
Daewoong Pharmaceutical begins the first administration of the Bersiporocin, new treatment for idiopathic pulmonary fibrosis, as Phase II clinical trial
-
Mesoblast Resubmits BLA for Remestemcel-L
-
Eisai’s New Alzheimer’s Drug Leqembi Hits the U.S. Market
-
Ground-breaking results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients
-
Gilead buoyed by Trodelvy OK in new breast cancer use
-
Medicago to Shut Down Despite COVID-19 Vaccine Approval
-
US FDA approves Ellipses Pharma’s IND for AML therapy
-
ICER Questions Benefit of Fezolinetant for Hot Flashes